Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 11 results.
User Information
Export Records
  1. 1.   Bifunctional fusion proteins of the human engineered antibody domain m36 with human soluble CD4 are potent inhibitors of diverse HIV-1 isolates
  2. Chen, W. Z.; Xiao, X. D.; Wang, Y. P.; Zhu, Z. Y.; Dimitrov, D. S.
  3. Antiviral Research. 2010, Oct; 88(1): 107-115.
  1. 2.   Potent antibody-mediated neutralization and evolution of antigenic escape variants of simian immunodeficiency virus strain SIVmac239 in vivo
  2. Sato, S.; Yuste, E.; Lauer, W. A.; Chang, E. H.; Morgan, J. S.; Bixby, J. G.; Lifson, J. D.; Desrosiers, R. C.; Johnson, W. E.
  3. Journal of Virology. 2008 82(19): 9739-9752.
  1. 3.   Trp/Met/Phe hot spots in protein-protein interactions: Potential targets in drug design
  2. Ma, B.; Nussinov, R.
  3. Current Topics in Medicinal Chemistry. 2007 7(10): 999-1005.
  1. 4.   Structural mimicry of CD4 by a cross-reactive HIV-1 neutralizing antibody with CDR-H2 and H3 containing unique motifs
  2. Prabakaran, P.; Gan, J. H.; Wu, Y. Q.; Zhang, M. Y.; Dimitrov, D. S.; Ji, X. H.
  3. Journal of Molecular Biology. 2006, MAR 17; 357(1): 82-99.
  1. 5.   Structure of a V3-containing HIV-1 gp120 core
  2. Huang, C. C.; Tang, M.; Zhang, M. Y.; Majeed, S.; Montabana, E.; Stanfield, R. L.; Dimitrov, D. S.; Korber, B.; Sodroski, J.; Wilson, I. A.; Wyatt, R.; Kwong, P. D.
  3. Science. 2005, NOV 11; 310(5750): 1025-1028.
  1. 6.   Structural basis of tyrosine sulfation and V-H-gene usage in antibodies that recognize the HIV type 1 coreceptor-binding site on gp120
  2. Huang, C. C.; Venturi, M.; Majeed, S.; Moore, M. J.; Phogat, S.; Zhang, M. Y.; Dimitrov, D. S.; Hendrickson, W. A.; Robinson, J.; Sodroski, J.; Wyatt, R.; Choe, H.; Farzan, M.; Kwong, P. D.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2004 101(9): 2706-2711.
  1. 7.   Identification and characterization of peptides that bind to cyanovirin-N, a potent human immunodeficiency virus-inactivating protein
  2. Han, Z. Z.; Simpson, J. T.; Fivash, M. J.; Fisher, R.; Mori, T.
  3. Peptides. 2004 25(4): 551-561.
  1. 8.   Access of antibody molecules to the conserved coreceptor binding site on glycoprotein gpl120 is sterically restricted on primary human immunodeficiency virus type 1
  2. Labrijn, A. F.; Poignard, P.; Raja, A.; Zwick, M. B.; Delgado, K.; Franti, M.; Binley, J.; Vivona, V.; Grundner, C.; Huang, C. C.; Venturi, M.; Petropoulos, C. J.; Wrin, T.; Dimitrov, D. S.; Robinson, J.; Kwong, P. D.; Wyatt, R. T.; Sodroski, J.; Burton, D. R.
  3. Journal of Virology. 2003 77(19): 10557-10565.
  1. 9.   DNA vaccines encoding human immunodeficiency virus-1 glycoprotein 120 fusions with proinflammatory chemoattractants induce systemic and mucosal immune responses
  2. Biragyn, A.; Belyakov, I. M.; Chow, Y. H.; Dimitrov, D. S.; Berzofsky, J. A.; Kwak, L. W.
  3. Blood. 2002 100(4): 1153-1159.
  1. 10.   Discovery of a stable dimeric mutant of cyanovirin-N (CV-N) from a T7 phage-displayed CV-N mutant library
  2. Han, Z. Z.; Xiong, C. Y.; Mori, T.; Boyd, M. R.
  3. Biochemical and Biophysical Research Communications. 2002 292(4): 1036-1043.
  1. 11.   Broadly cross-reactive HIV-1-neutralizing human monoclonal Fab selected for binding to gp120-CD4-CCR5 complexes
  2. Moulard, M.; Phogat, S. K.; Shu, Y.; Labrijn, A. F.; Xiao, X. D.; Binley, J. M.; Zhang, M. Y.; Sidorov, I. A.; Broder, C. C.; Robinson, J.; Parren, P.; Burton, D. R.; Dimitrov, D. S.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2002 99(10): 6913-6918.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel